6
Total deals
$1.3B
Total value
$251.1M
Avg deal
$500.0M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Definiens
Definiens provides image analysis and data mining solutions for quantitative dig…
|
2014-11-04 | Acquisition | Complete | $150.0M | Deal → |
| 2 |
Allozyne
Allozyne develops technologies that improve the efficacy, safety, dosing, and ot…
|
2014-09-19 | Acquisition | Complete | $5.5M | Deal → |
| 3 |
Spirogen
Spirogen is a clinical stage biotechnology company specialising in novel, sequen…
|
2013-10-15 | Acquisition | Complete | $440.0M | Deal → |
| 4 |
Amplimmune
Amplimmune is a product-driven company offering immune-based biologics to treat …
|
2013-08-27 | Acquisition | Complete | $500.0M | Deal → |
| 5 |
A
AlphaCore Pharma
AlphaCore Pharma operates as a biopharmaceutical company.
|
2013-04-03 | Acquisition | Complete | — | Deal → |
| 6 |
Cellective Therapeutics
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell re…
|
2005-09-15 | Acquisition | Complete | $160.0M | Deal → |